started · updated
Poland Ministry of Health proposes new NFZ diagnostic tests
The Polish Ministry of Health is proposing changes to the list of diagnostic tests covered by the National Health Fund (NFZ), scheduled to take effect on January 1, 2027. The initiative aims to address three specific patient needs: clarifying elevated hormone levels, improving diagnostics for intestinal diseases, and ensuring safer monitoring of oncological treatments.
Key updates include the addition of macroprolactin testing to investigate high prolactin concentrations and the inclusion of mitotane concentration testing to monitor adrenocortical cancer treatment. Additionally, older celiac disease tests will be replaced with more modern antibody testing for tissue transglutaminase in IgA and IgG classes.
These changes apply to diagnostics ordered for medical indications within outpatient specialist care. The proposal does not create a universal preventive package or expand the list of tests that primary care physicians can order; instead, specialists will prescribe these tests as part of ongoing diagnostics or treatment monitoring.